BNGO round 2!!!!
This play looks tempting ngl. 
BNGO
Bionanon made very tasty returns so why not return. Price is near 0+/- ATR in keltner and if it closes above I will enter.
Last time I entered around $5 and avg'ED up till $5.6.
Took Profit around $14 but this chart looks promising.
Genomics is still an underrated sector and there are many supporters of its hot product -' The Saphyre system'
Let's see how this runs. Good luck
Entry - $7-$8 since it bottomed at $6.90. Set trailing SL of 15%.
TP - $9-$10, since it might test resistance and bounce back down. Great company but burns through cash, so some major hyped event would need to occur for it to retest ATH.
(Disclaimer this is not financial advice just my opinion)
BNGOBionanon made very tasty returns so why not return. Price is near 0+/- ATR in keltner and if it closes above I will enter.
Last time I entered around $5 and avg'ED up till $5.6.
Took Profit around $14 but this chart looks promising.
Genomics is still an underrated sector and there are many supporters of its hot product -' The Saphyre system'
Let's see how this runs. Good luck
Entry - $7-$8 since it bottomed at $6.90. Set trailing SL of 15%.
TP - $9-$10, since it might test resistance and bounce back down. Great company but burns through cash, so some major hyped event would need to occur for it to retest ATH.
(Disclaimer this is not financial advice just my opinion)
Publications connexes
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Publications connexes
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.